Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

被引：0
|
作者：
Khan, S. [1 ]
Butler, J. [2 ]
Young, R. [1 ]
Lewis, B. S. [3 ]
Escobedo, J. [4 ]
Refsgaard, J. [5 ]
Reyes, E. [6 ]
Roessig, L. [7 ]
Blaustein, R. O. [8 ]
Lam, C. S. P. [9 ]
Voors, A. A. [10 ]
Ponikowski, P. [11 ]
Anstrom, K. J. [1 ]
Armstrong, P. [12 ]
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] Baylor Univ, Med Ctr, Dallas, TX USA
[3] Lady Davis Carmel Med Ctr, Haifa, Israel
[4] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico
[5] Reg Hosp Viborg, Viborg, Denmark
[6] Philippine Gen Hosp, Manila, Philippines
[7] Bayer AG, Wuppertal, Germany
[8] Merck & Co Inc, Rahway, NJ USA
[9] Duke Natl Univ Singapore, Natl Heart Ctr Singapore, Singapore, Singapore
[10] Univ Med Ctr Groningen, Groningen, Netherlands
[11] Wroclaw Med Univ, Wroclaw, Poland
[12] Univ Alberta, Edmonton, AB, Canada
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Diuretic use and outcomes in patients with HFrEF: Insights from the VICTORIA trial
    Ezekowitz, J. A.
    Alemayehu, W.
    Edelmann, F.
    Ponikowski, P.
    Lam, C. S. P.
    O'connor, C. M.
    Butler, J.
    Homering, M.
    Corda, S.
    Mcmullan, C. J.
    Westerhout, C. M.
    Voors, A. A.
    Mentz, R. J.
    Armstrong, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [42] Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial
    Banks, Adam Z.
    Mentz, Robert J.
    Stebbins, Amanda
    Mikus, Catherine R.
    Schulte, Phillip J.
    Fleg, Jerome L.
    Cooper, Lawton S.
    Leifer, Eric S.
    Badenhop, Dalynn T.
    Keteyjan, Steven J.
    Pina, Ileana L.
    Kitzman, Dalane W.
    Fiuzat, Mona
    Whellan, David J.
    Kraus, William E.
    O'Connor, Christopher M.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (07) : 485 - 491
  • [43] Outcomes of Patients With Diabetes Versus Patients Without Diabetes Hospitalized With Acute Heart Failure
    Wan, Siu-Hin
    Slusser, Joshua P.
    Hodge, David O.
    Chen, Horng H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 165 : 65 - 71
  • [44] Generalizability of the Victoria Trial and the US FDA Label for Vericiguat to Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the United States
    Khan, Mohammad S.
    Xu, Haolin
    Fonarow, Gregg C.
    Lautsch, Dominik
    Hilkert, Robert J.
    Tan, Xi
    Allen, Larry A.
    Devore, Adam D.
    Alhanti, Brooke
    Pina, Ileana L.
    Albert, Nancy M.
    Butler, Javed
    Greene, Stephen J.
    CIRCULATION, 2022, 146
  • [45] Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial
    Esteban-Fernandez, Alberto
    Recio-Mayoral, Alejandro
    Lopez-Vilella, Raquel
    de Lara, Gregorio
    Barrantes-Castillo, Moises
    Gomez-Otero, Ines
    Nunez-Villota, Julio
    Robles-Gamboa, Carolina
    Lopez-Aguilera, Jose
    Iniesta-Manjavacas, Angel
    Fluvia, Paula
    Pastor-Perez, Francisco
    Belarte-Tornero, Laia
    Alonso-Salinas, Gonzalo
    Diez-Villanueva, Pablo
    VERISEC Registry Researchers
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2025, 11
  • [46] Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial
    Pieske, Burkert
    Patel, Mahesh J.
    Westerhout, Cynthia M.
    Anstrom, Kevin J.
    Butler, Javed
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Koglin, Joerg
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Roessig, Lothar
    Voors, Adriaan A.
    O'Connor, Christopher M.
    Armstrong, Paul W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (12) : 1596 - 1604
  • [47] Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Ferreira, Joao Pedro
    Neves, Joao Sergio
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11)
  • [48] Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: the VICTORIA echocardiographic substudy
    Pieske, Burkert
    Pieske-Kraigher, Elisabeth
    Lam, Carolyn S. P.
    Melenovsky, Vojtech
    Sliwa, Karen
    Lopatin, Yuri
    Arango, Juan Luis
    Bahit, M. Cecilia M.
    O'Connor, Christopher M. J.
    Patel, Mahesh J.
    Roessig, Lothar A.
    Morris, Daniel A.
    Kropf, Martin M.
    Westerhout, Cynthia M.
    Zheng, Yinggan W.
    Armstrong, Paul W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 1012 - 1021
  • [49] Geographic variation in heart failure with reduced ejection fraction: insights from the VICTORIA trial
    Tsutsui, H.
    Lam, C. S. P.
    Zhang, J.
    Godoy-Palomino, A.
    Tziakas, D.
    Cohen-Solal, A.
    Freitas, C.
    Patel, M. J.
    Ezekowitz, J. A.
    Hernandez, A. F.
    Pieske, B.
    O'Connor, C. M.
    Westerhout, C. M.
    Alemayehu, W.
    Armstrong, P. W.
    EUROPEAN HEART JOURNAL, 2022, 43 : 835 - 835
  • [50] Clinical Characteristics and Outcomes of Patients With and Without Diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial
    MacDonald, Michael R.
    She, Lilin
    Doenst, Torsten
    Binkley, Philip
    Rouleau, Jean
    San, Tan
    Lee, Kerry
    Sopko, George
    Szalewski, Dominika
    Velazquez, Eric
    Petrie, Mark C.
    CIRCULATION, 2014, 130
12345